Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation
Rémi Bonjean, R and D Project Manager at Nanomunity, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I share with you the work we have done in collaboration with the Pr Marie-Christine Alessi from Cardiovascular and Nutrition Research Center – (C2VN) and Dr Patrick Chames in the article ‘Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers’ a method article published in the journal Research and Practice in Thrombosis and Haemostasis.
In this article, we successfully developed, produced the first generation of VHHs against active Rap1 as promising tools to quantify active Rap1 levels in platelets and facilitate clinical studies to monitor platelet Rap1 activation in various medical contexts.
I would like to thank all authors who contributed to this collaboration especially Pr Marie-Christine Alessi, Dr Patrick Chames, Dr Maxime Moulard and Marielle Margier.”
Title: Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers
Authors: Marie-Christine Alessi, Maxime Moulard, Daniele Boulay-Moine, Cyril Pons, Marielle Margier, Cléa Vessière, Marjorie Poggi, Theo Pigaglio, Francoise Dignat-George, Alain Roussel, Stéphane Burtey, Laurent Bonello, Patrick Chames, Remi Bonjean, Franck Peiretti
Read the Full Article on RPTH Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation